Skip to content

Clinical trials

Phase 2 Gaucher Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gaucher Disease Phase: Phase 2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20081
20091
20121
20142
20151
20171
20181
20191
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics3
Genzyme, a Sanofi Company2
National Institute of Neurological Disorders and Stroke (NINDS)2
Azafaros B.V.1
Children's Hospital Medical Center, Cincinnati1
Hadassah Medical Organization1
National Center for Research Resources (NCRR)1
Paul Szabolcs1
Peking Union Medical College Hospital1
Protalix1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gaucher Disease18
Metabolism, Inborn Errors2
Rare Diseases2
Sphingolipidoses2
Adrenoleukodystrophy1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Arthritis, Juvenile1
Autoimmune Lymphoproliferative Syndrome1
Bone Diseases1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.